These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34039328)

  • 1. Is prophylactic lateral lymph node dissection needed for lower rectal cancer? A single-center retrospective study.
    Kondo H; Yamaguchi S; Hirano Y; Aikawa M; Sato H; Okamoto K; Sakuramoto S; Koyama I
    BMC Surg; 2021 May; 21(1):261. PubMed ID: 34039328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer].
    Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility of a three-sided encapsulation procedure based on fascia anatomy in laparoscopic lateral lymph node dissection for middle and low rectal cancer].
    Li WJ; Diao DC; Lin JX; Wang JH; Liao WL; Tang X; Xie JX; Ao L; Zhang XY; Yi XJ; Feng XC; Li HM; Lu XQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):968-976. PubMed ID: 37849268
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
    Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
    BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y;
    Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological outcomes of lateral lymph node dissection (LLND) for locally advanced rectal cancer: is LLND alone sufficient?
    Ishibe A; Watanabe J; Suwa Y; Suzuki S; Nakagawa K; Suwa H; Ozawa M; Ota M; Fujii S; Ike H; Ichikawa Y; Endo I
    Int J Colorectal Dis; 2021 Feb; 36(2):293-301. PubMed ID: 32965528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-team lateral lymph node dissection assisted by the transanal approach for locally advanced lower rectal cancer: comparison with the conventional transabdominal approach.
    Narihiro S; Kitaguchi D; Ikeda K; Hasegawa H; Teramura K; Tsukada Y; Nishizawa Y; Ito M
    Surg Endosc; 2023 Jul; 37(7):5256-5264. PubMed ID: 36973567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND.
    Kanemitsu Y; Komori K; Shida D; Ochiai H; Tsukamoto S; Kinoshita T; Moriya Y
    Surgery; 2017 Aug; 162(2):303-314. PubMed ID: 28366499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
    Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
    Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of lateral lymph node dissection in squamous cell carcinoma of the anal canal: a retrospective cohort study.
    Komori K; Yamada K; Ajioka Y; Sugihara K
    Langenbecks Arch Surg; 2024 May; 409(1):157. PubMed ID: 38735992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
    Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
    Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Significance of Lateral Lymph Node Metastasis in Low Rectal Cancer: a Propensity Score Matching Study.
    Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Yamaguchi S
    J Gastrointest Surg; 2021 Jul; 25(7):1866-1874. PubMed ID: 33078319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
    Kim MJ; Chang GJ; Lim HK; Song MK; Park SC; Sohn DK; Chang HJ; Kim DY; Park JW; Jeong SY; Oh JH
    Ann Surg Oncol; 2020 Sep; 27(9):3525-3533. PubMed ID: 32385767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy.
    Matsuda T; Hasegawa H; Yamashita K; Tanaka T; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Sumi Y; Suzuki S; Kakeji Y
    Surg Endosc; 2020 Mar; 34(3):1425-1431. PubMed ID: 31628619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.